Astria Therapeutics Competitors and Similar CompaniesClear all

Astria Therapeutics's competitors and similar companies include ESSA Pharma, Zonsen Peplib Biotech, Imvaq Therapeutics and ColonaryConcepts.

	Astria Therapeutics Astria Therapeutics (formerly known as Catabasis Pharmaceuticals) discovers and develops innovative drugs for treating inflammatory conditions.	ESSA Pharma ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer.	Zonsen Peplib Biotech Zonsen Peplib Biotech is a platform-based company that develops peptide-leading drugs.	Imvaq Therapeutics Imvaq Therapeutics is a company that develops cancer immunotherapy solutions.	ColonaryConcepts ColonaryConcepts is a pharmaceutical development company focused on technology platforms that promote gastrointestinal health.
Founding Date	Founding Date 2008	Founding Date 2009	Founding Date 2017	Founding Date 2016	Founding Date 2013
Type	Type Public	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare drug development pharma platform	Tags Manufacturing & Industrial drug development oncology pharma	Tags Healthcare drug development pharma platform	Tags Healthcare drug development pharma platform	Tags Healthcare drug development pharma platform
Locations	Locations Boston, US HQ	Locations Vancouver, CA HQ Houston, US South San Francisco, US	Locations Zhuzhou, CN HQ Metuchen, US	Locations Sammamish, US HQ	Locations HQ
Employees	Employees 2433% decrease	Employees 35	Employees N/A	Employees 2	Employees 3
Valuation ($)	Valuation ($) 683.3 m	Valuation ($) 240 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Net income	Net income ($94.3m) (FY, 2024)	Net income ($28.5m) (FY, 2024)	Net income N/A	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 34m (about 5 years ago)	Latest funding round N/A	Latest funding round $ 1m (about 8 years ago)
Total funding raised	Total funding raised $ 94.9m	Total funding raised $ 74.1m	Total funding raised $ 48m	Total funding raised N/A	Total funding raised $ 9.9m